Rigrodsky & Long, P.A. Announces Investigation Of Obagi Medical Products, Inc. Buyout

  Rigrodsky & Long, P.A. Announces Investigation Of Obagi Medical Products,
  Inc. Buyout

Business Wire

WILMINGTON, Del. -- March 21, 2013

Rigrodsky & Long, P.A.:

  *Do you own shares of Obagi Medical Products, Inc. (NASDAQ GS: OMPI)?
  *Did you purchase any of your shares prior to March 20, 2013?
  *Do you think the proposed buyout price is too low?
  *Do you want to discuss your rights?

Rigrodsky & Long, P.A. announces that it is investigating potential legal
claims against the board of directors of Obagi Medical Products, Inc. (“Obagi”
or the “Company”) (NASDAQ GS: OMPI) regarding possible breaches of fiduciary
duties and other violations of law related to the Company’s entry into an
agreement to be acquired by Valeant Pharmaceuticals International, Inc.
(“Valeant”) (NYSE: VRX) in a transaction valued at approximately $344 million.

Click here to learn more:
http://www.rigrodskylong.com/investigations/obagi-medical-products-inc-ompi.

Under the terms of the proposal, public shareholders of Obagi will receive
$19.75 per share in cash for each share of Obagi they own.

The investigation concerns whether Obagi’s board of directors failed to
adequately shop the Company and obtain the best possible value for Obagi’s
shareholders before entering into an agreement with Valeant.

If you own the common stock of Obagi and purchased your shares before March
20, 2013, if you have information or would like to learn more about these
claims, or if you wish to discuss these matters or have any questions
concerning this announcement or your rights or interests with respect to these
matters, please contact Seth Rigrodsky or Brian Long at Rigrodsky & Long,
P.A., 2 Righter Parkway, Suite 120, Wilmington, Delaware 19803, by telephone
at (302) 295-5310, or Peter Allocco at Rigrodsky & Long, P.A., 825 East Gate
Boulevard, Suite 300, Garden City, New York 11530, by telephone at (888)
969-4242; by e-mail to info@rigrodskylong.com, or at:
http://www.rigrodskylong.com/investigations/obagi-medical-products-inc-ompi.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City,
New York, regularly prosecutes securities class, derivative and direct
actions, shareholder rights litigation and corporate governance litigation, on
behalf of shareholders in states and federal courts throughout the United
States.

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Brian D. Long
Peter Allocco
888-969-4242
302-295-5310
516-683-3516
Fax: 302-654-7530
info@rigrodskylong.com
http://www.rigrodskylong.com
 
Press spacebar to pause and continue. Press esc to stop.